Bayer, J&J Look To Bar Amended Master Xarelto Complaint
By Matt Fair ( March 7, 2018, 7:44 PM EST) -- A pair of Bayer AG and Johnson & Johnson units have urged a Pennsylvania judge to bar a substantially amended master complaint in a mass tort program over the blood-thinner Xarelto from being filed as they gear up for a set of bellwether trials to begin next month....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.